Document is current
Any future updates will be listed below
-
Authors
Dahiya, Monica
Eboreime, Ejemai
Hyde, Ashley
Rahman, Sholeh
Sebastianski, Meghan
Carbonneau, Michelle
Tapper, Elliot B.
Tandon, Puneeta https://orcid.org/0000-0002-9698-5814
-
Funding
Funding for this research was provided by:
Alberta Innovates (PRIHS Grant)
- License Information
-
More Information
Article History
Received: 30 March 2021
Accepted: 24 May 2021
First Online: 6 June 2021
Declarations
:
: ET reports grant funding from Gilead and Bausch, consulted for Kaleido, Axcella, Novo Nordisk, Novartis and Allergan, and has served on advisory boards for Bausch and Mallinckrodt. PT has served on the advisory board for Lupin Pharma Canada. The remaining authors do not have any conflicts of interest to disclose.
